Figure 3. Expression of cortical signature of Alzheimer disease (AD) is associated with AD-like spinal fluid.

Cognitively normal participants who were classified as high risk for preclinical AD on the basis of having low AD-signature cortical thickness showed a trend toward being more likely to harbor abnormally low amyloid-β levels in CSF compared to participants with average or high AD-signature cortical thickness.